Tag Archives: Building

Novartis building out cell and gene therapy platform that'll lead the pack, CEO promises

SAN FRANCISCO—Novartis’ first-ever CAR-T cell therapy may have been hamstrung by early manufacturing problems, but the company still figures it can build a cell and gene therapy platform strong enough to deliver success not only with Kymriah but also a full “game board” of treatments for many more diseases, its CEO said on Monday. During his first… Read More »